ASNS · Insider Trading
ACTELIS NETWORKS INC
Every open-market purchase and sale reported by ASNS officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-11-06 | Yaron Altit | Exec VP International Sales | A | +30,000 deriv. | — |
| 2025-11-06 | Maurice Niel Ransom | Director | A | +138,889 deriv. | — |
| 2025-11-06 | Yoav Efron | CFO and Deputy CEO | A | +138,889 deriv. | — |
| 2025-11-06 | Elad Domanovitz | Chief Technology Officer | A | +30,000 deriv. | — |
| 2025-11-06 | Mark DeVol | CRO Americas | A | +100,000 deriv. | — |
| 2025-11-06 | Hemi Kabir | Vice President Operations | A | +30,000 deriv. | — |
| 2025-11-06 | Tuvia Barlev | CEO | A | +694,444 deriv. | — |
| 2025-11-06 | Eyal Aharon | Vice President R&D | A | +30,000 deriv. | — |
| 2025-11-06 | Michal Winkler-Solomon | Vice President Marketing | A | +30,000 deriv. | — |
| 2025-11-06 | Gideon Marks | Director | A | +138,889 deriv. | — |
| 2025-11-06 | Julie Anne Kunstler | Director | A | +138,889 deriv. | — |
| 2024-04-02 | Tuvia Barlev | CEO and Chairman of the Board | Sell | +8,965 | +$9.95K |
| 2023-12-19 | Bret Harrison | Senior VP Sales, Americas | A | +5,000 deriv. | — |
| 2023-12-15 | Tuvia Barlev | CEO and Chairman of the Board | Sell | — | — |
| 2023-12-12 | Michal Winkler-Solomon | Vice President Marketing | Sell | −205 | −$228 |
| 2023-06-21 | Yaron Altit | Exec VP International Sales | A | +4,000 deriv. | — |
| 2023-06-21 | Eyal Aharon | Vice President R & D | A | +2,700 deriv. | — |
| 2023-06-21 | Michal Winkler-Solomon | Vice President Marketing | A | +2,600 deriv. | — |
| 2023-06-21 | Elad Domanovitz | Chief Technology Officer | A | +1,800 deriv. | — |
| 2023-06-21 | Hemi Kabir | Vice President, Operations | A | +2,700 deriv. | — |
| 2023-05-18 | Tuvia Barlev | CEO and Chairman of the Board | Sell | −2,107 | −$7.00K |
| 2023-05-18 | Israel Niv | Director | Sell | −422 | −$1.40K |
| 2022-12-19 | Eyal Aharon | Vice President R & D | A | +20,000 deriv. | — |
| 2022-12-19 | Michal Winkler-Solomon | Vice President Marketing | A | +12,000 deriv. | — |
| 2022-12-19 | Hemi Kabir | Vice President, Operations | A | +16,000 deriv. | — |
| 2022-12-19 | Jan Ruderman | CRO-Americas | A | +68,000 deriv. | — |
| 2022-12-19 | Elad Domanovitz | Chief Technology Officer | A | +12,000 deriv. | — |
| 2022-12-19 | Yaron Altit | Vice President Marketing | A | +8,000 deriv. | — |
| 2022-12-19 | Bruce Hammergren | EVP Sales Americas | A | +6,000 deriv. | — |
| 2022-09-19 | Bruce Hammergren | EVP Sales Americas | A | +2,173 deriv. | — |
| 2022-09-19 | Eyal Aharon | Vice President R & D | A | +3,193 deriv. | — |
| 2022-09-19 | Yoav Efron | Chief Financial Officer | A | +25,000 deriv. | — |
| 2022-09-19 | Joseph Moscovitz | Director | A | +25,000 deriv. | — |
| 2022-09-19 | Michal Winkler-Solomon | Vice President Marketing | A | +4,437 deriv. | — |
| 2022-09-19 | Jan Ruderman | CRO-Americas | A | +21,739 deriv. | — |
| 2022-09-19 | Noemi Schmayer | Director | A | +25,000 deriv. | — |
| 2022-09-19 | Israel Niv | Director | A | +25,000 deriv. | — |
| 2022-09-19 | Hemi Kabir | Vice President, Operations | A | +3,260 deriv. | — |
| 2022-09-19 | Tuvia Barlev | CEO and Chairman of the Board | A | +125,000 deriv. | — |
| 2022-09-19 | Naama Halevi-Davidov | Director | A | +25,000 deriv. | — |
| 2018-11-28 | Michael Gray | President, CEO and CFO | A | +250,000 | — |
| 2018-06-07 | Tillman U. Gerngross | Director | A | +10,000 deriv. | — |
| 2018-06-07 | David W J McGirr | Director | A | +10,000 deriv. | — |
| 2018-06-07 | Amy W Schulman | Director | A | +10,000 deriv. | — |
| 2018-06-07 | Michael Jay Ross | Director | A | +10,000 deriv. | — |
| 2018-06-07 | Terrance McGuire | Director | A | +10,000 deriv. | — |
| 2018-06-07 | Claudio Nessi | Director | A | +10,000 deriv. | — |
| 2018-06-07 | William D Clark | Director | A | +10,000 deriv. | — |
| 2018-06-07 | Carl L Gordon | Director | A | +10,000 deriv. | — |
| 2018-03-09 | Eszter Nagy | Chief Scientific Officer | A | +45,000 deriv. | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Tuvia Barlev | CEO | 17,050 | $1.33K |
| Michal Winkler-Solomon | Vice President Marketing | 427 | $33 |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the ASNS quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.